Published on 4 May 2023 on Zacks via Yahoo Finance
Deciphera Pharmaceuticals, Inc. DCPH reported a first-quarter 2023 loss of 60 cents per share, which was in line with the Zacks Consensus Estimate. In the year-ago quarter, DCPH had reported a loss of 80 cents per share.
Total net revenues were $33.4 million in the quarter, missing the Zacks Consensus Estimate of $35 million. Revenues rose 15% year over year.
Shares of Deciphera have rallied 31% in the year so far against the industry’s decline of 6.2%.